Condition: Hidradenitis Suppurativa (HS) · Sponsor: Incyte Corporation
Rollover study for participants from predetermined, Incyte-sponsored parent clinical trials of povorcitinib.
This description comes directly from the study's public registry record.
Incyte Corporation Call Center (US) · 1.855.463.3463 · medinfo@incyte.com
Incyte Corporation Call Center (ex-US) · +800 00027423 · eumedinfo@incyte.com
Always discuss trial participation with your own doctor first.
| Investigative Site US106 | Birmingham, Alabama, United States | Not Yet Recruiting |
| Investigative Site US086 | Birmingham, Alabama, United States | Recruiting |
| Investigative Site US098 | Montgomery, Alabama, United States | Not Yet Recruiting |
| Investigative Site US004 | Phoenix, Arizona, United States | Recruiting |
| Investigative Site US047 | Scottsdale, Arizona, United States | Withdrawn |
| Investigative Site US115 | Tucson, Arizona, United States | Not Yet Recruiting |
| Investigative Site US076 | Fountain Valley, California, United States | Recruiting |
| Investigative Site US077 | Fremont, California, United States | Recruiting |
| Investigative Site US071 | Huntington Beach, California, United States | Recruiting |
| Investigative Site US097 | Irvine, California, United States | Not Yet Recruiting |
| Investigative Site US020 | Laguna Niguel, California, United States | Recruiting |
| Investigative Site US036 | Los Angeles, California, United States | Recruiting |
+ 306 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06855498